Avita Therapeutics Inc. logo

Avita Therapeutics Inc. (US05380C1027)

Delisted
XSTU XSTU
Want to track US05380C1027 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

US05380C1027 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on CXA (AUD).

Avita Therapeutics Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. James M. Corbett CEO
XSTU Exchange
- ISIN
US Country
260 Employees
- Last Dividend
24 Jun 2020 Last Split
- IPO Date

Overview

AVITA Medical, Inc., together with its subsidiaries, functions within the regenerative medicine realm on an international scale, with a focus on the United States. Initially known as AVITA Therapeutics, Inc., the entity underwent a name change, establishing itself as AVITA Medical, Inc. in 2020. The company has firmly rooted its headquarters in Valencia, California. It specializes in providing innovative medical devices and solutions, primarily catering to the treatment of various skin conditions and wounds through regeneration and repair mechanisms.

Products and Services

AVITA Medical, Inc. is at the forefront of regenerative medicine with its pioneering products:

  • RECELL System - This flagship product stands as a groundbreaking cell harvesting device designed for the treatment of thermal burn wounds and full-thickness skin defects. It offers a unique approach to skin regeneration, allowing for the repigmentation of stable depigmented vitiligo lesions. The RECELL System encapsulates the company’s commitment to enhancing the healing process and improving patient outcomes through innovative technology.
  • RECELL GO - As an extension of their product line, AVITA Medical is currently developing the RECELL GO, which seeks to streamline and control the manual processes involved in cell disaggregation, filtration, and soak time. This product is aimed at making the application of regenerative medicine more efficient and effective, thereby broadening the scope of treatments AVITA Medical can offer to its patients.

Contact Information

Address: 28159 Avenue Stanford
Phone: 661 367 9170